Global /United States /Healthcare /Medical Devices /EBR
chevron_leftBack
EBR Systems, Inc. logo

EBR Systems, Inc.

EBR
• ASX: EBR • Delayed
0.6300AUD 2.4%
0.4431 USD
As of 13 June 2026, EBR Systems, Inc. has a market cap of $199.52M USD, ranking #21088 globally and #3438 in the United States. It ranks #1888 in the Healthcare sector, and #390 in the Medical Devices industry.
Global Rank
21088
Country Rank
3438
Sector Rank
1888
Industry Rank
390
Key Stats
Market Cap
$199.52MUSD
283.84M AUD
Enterprise Value
$204.25MUSD
290.42M AUD
Revenue (TTM)
$1.7MUSD
2.42M AUD
EBITDA (TTM)
-$48.17MUSD
-68.49M AUD
Net Income (TTM)
-$51.38MUSD
-73.1M AUD
PS Ratio
117.1
PB Ratio
7.4
Company Profile
Country (HQ)
United States
Sector
Healthcare
Industry
Medical Devices
CEO
John McCutcheon open_in_new
Employees
135
Founded
2003
Website
ebrsystemsinc.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.4% 2% -4.4% -33% -49% -48%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
EBR
EBR Systems Inc ADR
ISIN: AU0000182552
Shares Out.:
4.813B1
TV:
ASX: EBR
SA:
ASX: EBR
YF:
EBR.AX
GF:
ASX: EBR
BA:
EBR
MS:
XASX: EBR
0.6300 AUD
OTC Markets
MIC: OTCM
EBRCZ
EBR Systems Inc ADR
ISIN: AU0000182552
TV:
OTC: EBRCZ
SA:
OTC: EBRCZ
YF:
EBRCZ
GF:
OTCMKTS: EBRCZ
BA:
EBRCZ
MS:
PINX: EBRCZ
0.4239 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About EBR Systems, Inc.

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
Thermo Fisher Scientific Inc.
TMO
$173.27B
87K%
25.8
Intuitive Surgical, Inc.
ISRG
$160.73B
80K%
56.7
Abbott Laboratories
ABT
$159.07B
80K%
25.6
Danaher Corp.
DHR
$126.55B
63K%
34.7
Stryker Corp.
SYK
$120.69B
60K%
38.3
Boston Scientific Corp.
BSX
$84.93B
42K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
Medtronic plc
MDT
$101.9B
51K%
22.2
EssilorLuxottica Société anonyme
EL
$97.46B
84.32B EUR
49K%
36.7
HOYA Corp.
7741
$61.41B
9.83T JPY
31K%
40.0
Siemens Healthineers AG
SHL
$45.47B
39.34B EUR
23K%
18.7
Alcon Inc.
ALC
$36.38B
28.99B CHF
18K%
37.9
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
$30.06B
203.66B CNY
15K%
26.0
chevron_leftBack